Genzyme Laboratory achieves accreditation from College of American Pathologists as first commercial genetic testing facility

14-Dec-2009 - USA

Genzyme Corporation announced that its genetic testing laboratory located in Phoenix, Arizona, has obtained the CAP 15189SM accreditation to the International Standards Organization 15189:2007 Standard for laboratories from the College of American Pathologists. This accreditation recognizes the laboratory’s technical competence and continual quality management and underscores Genzyme’s commitment to improved patient outcomes by providing reliable test results.

The College of American Pathologists offers laboratories the opportunity to be measured against the quality standards outlined by the International Organization of Standardization. The College of American Pathologists rigorously assessed Genzyme’s quality management systems over the course of a full year before awarding it the CAP 15189 designation.

“Achieving this accreditation demonstrates our commitment to achieving superior quality standards and delivering overall operational excellence,” said Jon Hart, senior vice president and general manager of Genzyme Genetics, the business unit of Genzyme Corporation focused on complex testing services for pathology, oncology, reproductive and genetic medicine. “Going through the rigorous and extensive accreditation process has allowed us to mitigate risk and continually provide highly accurate test results to physicians and patients nationwide.”

Genzyme expects to pursue CAP 15189 accreditation in all of its genetic testing laboratories located throughout the United States.

https://www.bionity.com/en/news/110760/genzyme-laboratory-achieves-accreditation-from-college-of-american-pathologists-as-first-commercial-genetic-testing-facility.html